awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33419856-41D5E71B-FF66-442C-8AB1-A8657E8C493C
Q33419856-41D5E71B-FF66-442C-8AB1-A8657E8C493C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419856-41D5E71B-FF66-442C-8AB1-A8657E8C493C
Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer.
P2860
Q33419856-41D5E71B-FF66-442C-8AB1-A8657E8C493C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419856-41D5E71B-FF66-442C-8AB1-A8657E8C493C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae47f10fa24e8dd932497416591a07cdb43dc690
P2860
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.